The efficacy of a multidisciplinary team approach in critical limb ischemia. 2017

Hiroshi Suzuki, and Atsuo Maeda, and Hideyuki Maezawa, and Tomoichiro Togo, and Hitoshi Nemoto, and Yoshiaki Kasai, and Yoshinori Ito, and Tokio Nakada, and Hirohiko Sueki, and Aya Mizukami, and Mamiko Takayasu, and Kenji Iwaku, and Susumu Takeuchi, and Hiroyuki Tanaka, and Yoshitaka Iso
Division of Cardiology, Department of Internal Medicine, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, Kanagawa, 227-8501, Japan. hrsuzuki@med.showa-u.ac.jp.

The aim of the present study was to clarify the characteristics of Japanese critical limb ischemia (CLI) patients and analyze the rates of real-world mortality and amputation-free survival (AFS) in all patients with Fontaine stage IV CLI who were treated with/without revascularization therapy by an intra-hospital multidisciplinary care team. All consecutive patients who presented with CLI at Showa University Fujigaoka Hospital between April 2008 and March 2014 were prospectively registered. The intra-hospital committee consisted of cardiologists, plastic surgeons, dermatologists, diabetologists, nephrologists, cardiovascular surgeons, and vascular technologists. The primary endpoint of this study was all-cause mortality and AFS during the follow-up period. The present study included 145 patients with Fontaine stage IV CLI. The mean age was 76.5 ± 10.2 years. The all-cause mortality rate during the follow-up period (15.5 ± 16.1 months) was 21.4 %. The AFS rate during the follow-up period (14.1 ± 16.4 months) was 58.6 %. A multivariate Cox proportional hazards regression analysis found that age >75 years and hemodialysis were significantly associated with all-cause mortality; and that age >75 years, Rutherford 6, and wound infection were significantly associated with AFS. A multidisciplinary approach and comprehensive care may improve the outcomes and optimize the collaborative treatment of CLI patients. However, all-cause mortality remained high in patients with Fontaine stage IV CLI and early referral to a hospital that can provide specialized treatment for CLI, before the occurrence of major tissue loss or infection, is necessary to avoid primary amputation.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D010348 Patient Care Team Care of patients by a multidisciplinary team usually organized under the leadership of a physician; each member of the team has specific responsibilities and the whole team contributes to the care of the patient. Health Care Team,Interdisciplinary Health Team,Medical Care Team,Multidisciplinary Care Team,Multidisciplinary Health Team,Healthcare Team,Care Team, Health,Care Team, Medical,Care Team, Multidisciplinary,Care Team, Patient,Care Teams, Health,Care Teams, Patient,Health Care Teams,Health Team, Interdisciplinary,Health Team, Multidisciplinary,Healthcare Teams,Interdisciplinary Health Teams,Medical Care Teams,Multidisciplinary Care Teams,Multidisciplinary Health Teams,Patient Care Teams,Team, Health Care,Team, Healthcare,Team, Interdisciplinary Health,Team, Medical Care,Team, Multidisciplinary Care,Team, Multidisciplinary Health,Team, Patient Care,Teams, Interdisciplinary Health
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Hiroshi Suzuki, and Atsuo Maeda, and Hideyuki Maezawa, and Tomoichiro Togo, and Hitoshi Nemoto, and Yoshiaki Kasai, and Yoshinori Ito, and Tokio Nakada, and Hirohiko Sueki, and Aya Mizukami, and Mamiko Takayasu, and Kenji Iwaku, and Susumu Takeuchi, and Hiroyuki Tanaka, and Yoshitaka Iso
April 2021, The Journal of cardiovascular surgery,
Hiroshi Suzuki, and Atsuo Maeda, and Hideyuki Maezawa, and Tomoichiro Togo, and Hitoshi Nemoto, and Yoshiaki Kasai, and Yoshinori Ito, and Tokio Nakada, and Hirohiko Sueki, and Aya Mizukami, and Mamiko Takayasu, and Kenji Iwaku, and Susumu Takeuchi, and Hiroyuki Tanaka, and Yoshitaka Iso
March 2014, Seminars in vascular surgery,
Hiroshi Suzuki, and Atsuo Maeda, and Hideyuki Maezawa, and Tomoichiro Togo, and Hitoshi Nemoto, and Yoshiaki Kasai, and Yoshinori Ito, and Tokio Nakada, and Hirohiko Sueki, and Aya Mizukami, and Mamiko Takayasu, and Kenji Iwaku, and Susumu Takeuchi, and Hiroyuki Tanaka, and Yoshitaka Iso
June 2016, Techniques in vascular and interventional radiology,
Hiroshi Suzuki, and Atsuo Maeda, and Hideyuki Maezawa, and Tomoichiro Togo, and Hitoshi Nemoto, and Yoshiaki Kasai, and Yoshinori Ito, and Tokio Nakada, and Hirohiko Sueki, and Aya Mizukami, and Mamiko Takayasu, and Kenji Iwaku, and Susumu Takeuchi, and Hiroyuki Tanaka, and Yoshitaka Iso
January 2022, Missouri medicine,
Hiroshi Suzuki, and Atsuo Maeda, and Hideyuki Maezawa, and Tomoichiro Togo, and Hitoshi Nemoto, and Yoshiaki Kasai, and Yoshinori Ito, and Tokio Nakada, and Hirohiko Sueki, and Aya Mizukami, and Mamiko Takayasu, and Kenji Iwaku, and Susumu Takeuchi, and Hiroyuki Tanaka, and Yoshitaka Iso
May 2017, Annals of vascular surgery,
Hiroshi Suzuki, and Atsuo Maeda, and Hideyuki Maezawa, and Tomoichiro Togo, and Hitoshi Nemoto, and Yoshiaki Kasai, and Yoshinori Ito, and Tokio Nakada, and Hirohiko Sueki, and Aya Mizukami, and Mamiko Takayasu, and Kenji Iwaku, and Susumu Takeuchi, and Hiroyuki Tanaka, and Yoshitaka Iso
June 2019, Annals of vascular diseases,
Hiroshi Suzuki, and Atsuo Maeda, and Hideyuki Maezawa, and Tomoichiro Togo, and Hitoshi Nemoto, and Yoshiaki Kasai, and Yoshinori Ito, and Tokio Nakada, and Hirohiko Sueki, and Aya Mizukami, and Mamiko Takayasu, and Kenji Iwaku, and Susumu Takeuchi, and Hiroyuki Tanaka, and Yoshitaka Iso
April 2000, American journal of infection control,
Hiroshi Suzuki, and Atsuo Maeda, and Hideyuki Maezawa, and Tomoichiro Togo, and Hitoshi Nemoto, and Yoshiaki Kasai, and Yoshinori Ito, and Tokio Nakada, and Hirohiko Sueki, and Aya Mizukami, and Mamiko Takayasu, and Kenji Iwaku, and Susumu Takeuchi, and Hiroyuki Tanaka, and Yoshitaka Iso
February 2020, Journal de medecine vasculaire,
Hiroshi Suzuki, and Atsuo Maeda, and Hideyuki Maezawa, and Tomoichiro Togo, and Hitoshi Nemoto, and Yoshiaki Kasai, and Yoshinori Ito, and Tokio Nakada, and Hirohiko Sueki, and Aya Mizukami, and Mamiko Takayasu, and Kenji Iwaku, and Susumu Takeuchi, and Hiroyuki Tanaka, and Yoshitaka Iso
February 2015, Angiology,
Hiroshi Suzuki, and Atsuo Maeda, and Hideyuki Maezawa, and Tomoichiro Togo, and Hitoshi Nemoto, and Yoshiaki Kasai, and Yoshinori Ito, and Tokio Nakada, and Hirohiko Sueki, and Aya Mizukami, and Mamiko Takayasu, and Kenji Iwaku, and Susumu Takeuchi, and Hiroyuki Tanaka, and Yoshitaka Iso
October 2014, Circulation. Cardiovascular interventions,
Copied contents to your clipboard!